• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子κB受体活化因子配体激活破骨细胞前体中的核因子κB。

Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors.

作者信息

Wei S, Teitelbaum S L, Wang M W, Ross F P

机构信息

Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Endocrinology. 2001 Mar;142(3):1290-5. doi: 10.1210/endo.142.3.8031.

DOI:10.1210/endo.142.3.8031
PMID:11181547
Abstract

Receptor activator of nuclear factor-kappa B ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-kappa B activation. RANK-L also prompts macrophages to develop the osteoclast phenotype. Although NF-kappa B is essential for osteoclast differentiation, it is not known whether RANK-L activates this transcription complex in osteoclast precursors. We report that RANK-L rapidly induces NF-kappa B activation in both authentic osteoclast precursors, namely bone marrow macrophages, and RAW 264.7 cells, a murine macrophage line also capable of RANK-L-mediated osteoclastogenesis. Supershift studies reveal the RANK-L-induced DNA binding moiety contains p50/p65, the most common NF-kappa B complex. Subcellular translocation of p50 and p65 subunits is confirmed by Western blots and immunofluorescence analysis. RANK-L activates NF-kappa B in both bone marrow macrophages and RAW 264.7 cells by serine phosphorylation of I kappa B alpha within 5 min, resulting in rapid I kappa B alpha degradation and resynthesis. Attesting to function, RANK-L treatment of RAW 264.7 cells transiently transfected with a plasmid containing NF-kappa B consensus elements linked to luciferase greatly enhances reporter activity. Our data suggest that activation of the NF-kappa B pathway is an integral component of RANK-L-induced osteoclast differentiation.

摘要

核因子κB受体激活剂配体[RANK配体(RANK-L)]刺激成熟破骨细胞吸收骨质,这一过程与NF-κB激活相关。RANK-L还促使巨噬细胞发展为破骨细胞表型。尽管NF-κB对破骨细胞分化至关重要,但尚不清楚RANK-L是否在破骨细胞前体中激活这种转录复合体。我们报告称,RANK-L能在真正的破骨细胞前体即骨髓巨噬细胞以及RAW 264.7细胞(一种同样能够进行RANK-L介导的破骨细胞生成的小鼠巨噬细胞系)中迅速诱导NF-κB激活。超迁移研究表明,RANK-L诱导的DNA结合部分包含p50/p65,这是最常见的NF-κB复合体。p50和p65亚基的亚细胞易位通过蛋白质免疫印迹和免疫荧光分析得以证实。RANK-L通过在5分钟内使IκBα发生丝氨酸磷酸化,从而在骨髓巨噬细胞和RAW 264.7细胞中激活NF-κB,导致IκBα迅速降解并重新合成。用含有与荧光素酶相连的NF-κB共有元件的质粒瞬时转染RAW 264.7细胞后,RANK-L处理可显著增强报告基因活性,这证明了其功能。我们的数据表明,NF-κB信号通路的激活是RANK-L诱导破骨细胞分化不可或缺的组成部分。

相似文献

1
Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors.核因子κB受体活化因子配体激活破骨细胞前体中的核因子κB。
Endocrinology. 2001 Mar;142(3):1290-5. doi: 10.1210/endo.142.3.8031.
2
NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.表达RANK的破骨细胞祖细胞形成不需要NF-κB p50和p52的表达,但对于RANK和细胞因子介导的破骨细胞生成至关重要。
J Bone Miner Res. 2002 Jul;17(7):1200-10. doi: 10.1359/jbmr.2002.17.7.1200.
3
IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.白细胞介素-3直接作用于破骨细胞前体,并通过将细胞导向巨噬细胞谱系,不可逆地抑制核因子κB受体激活剂配体诱导的破骨细胞分化。
J Immunol. 2003 Jul 1;171(1):142-51. doi: 10.4049/jimmunol.171.1.142.
4
NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.N-甲基-D-天冬氨酸谷氨酸受体由破骨细胞前体表达,并参与破骨细胞生成的调节。
J Cell Biochem. 2003 Oct 1;90(2):424-36. doi: 10.1002/jcb.10625.
5
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.激活素A刺激破骨细胞前体中IkappaB-α/NFkappaB和RANK的表达以促进破骨细胞分化,但不刺激AKT存活通路。
J Cell Biochem. 2003 Sep 1;90(1):59-67. doi: 10.1002/jcb.10613.
6
Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.姜黄素(二阿魏酰甲烷)可抑制破骨细胞前体中核因子κB受体激活蛋白配体诱导的核因子κB激活,并抑制破骨细胞生成。
J Immunol. 2004 May 15;172(10):5940-7. doi: 10.4049/jimmunol.172.10.5940.
7
TNF-alpha expression is transcriptionally regulated by RANK ligand.肿瘤坏死因子-α(TNF-α)的表达受核因子κB受体活化因子配体(RANKL)的转录调控。
J Cell Physiol. 2005 Feb;202(2):371-8. doi: 10.1002/jcp.20127.
8
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.肿瘤坏死因子-α通过直接刺激暴露于允许水平的核因子κB受体活化因子配体的巨噬细胞来诱导破骨细胞生成。
J Clin Invest. 2000 Dec;106(12):1481-8. doi: 10.1172/JCI11176.
9
TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.TRAF2对于肿瘤坏死因子-α诱导的破骨细胞生成至关重要。
J Bone Miner Res. 2005 May;20(5):840-7. doi: 10.1359/JBMR.041225. Epub 2004 Dec 20.
10
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.肿瘤坏死因子-α(TNF)通过肿瘤坏死因子1型受体与核因子κB受体活化因子(RANK)信号通路的偶联刺激RANK配体(RANKL)诱导的破骨细胞生成。
J Biol Chem. 2001 Jan 5;276(1):563-8. doi: 10.1074/jbc.M008198200.

引用本文的文献

1
Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles.骨关节炎中的生物活性化合物:分子机制和治疗作用。
Int J Mol Sci. 2024 Oct 30;25(21):11656. doi: 10.3390/ijms252111656.
2
Effects of structured exercise programmes on physiological and psychological outcomes in adults with inflammatory bowel disease (IBD): A systematic review and meta-analysis.结构性运动方案对炎症性肠病(IBD)成人的生理和心理结果的影响:系统评价和荟萃分析。
PLoS One. 2022 Dec 1;17(12):e0278480. doi: 10.1371/journal.pone.0278480. eCollection 2022.
3
Downregulation of miR-21 gene expression by CRE-Ter to modulate osteoclastogenesis: De Novo mechanism.
通过CRE-Ter下调miR-21基因表达以调节破骨细胞生成:全新机制。
Biochem Biophys Rep. 2021 Apr 23;26:101002. doi: 10.1016/j.bbrep.2021.101002. eCollection 2021 Jul.
4
'Educated' Osteoblasts Reduce Osteoclastogenesis in a Bone-Tumor Mimetic Microenvironment.“受过教育”的成骨细胞在骨肿瘤模拟微环境中减少破骨细胞生成。
Cancers (Basel). 2021 Jan 12;13(2):263. doi: 10.3390/cancers13020263.
5
Comparative Characterization of Osteoclasts Derived From Murine Bone Marrow Macrophages and RAW 264.7 Cells Using Quantitative Proteomics.使用定量蛋白质组学对源自小鼠骨髓巨噬细胞和RAW 264.7细胞的破骨细胞进行比较表征。
JBMR Plus. 2018 Jul 7;2(6):328-340. doi: 10.1002/jbm4.10058. eCollection 2018 Nov.
6
Rosiglitazone suppresses RANKL-induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ.罗格列酮通过破坏NFATc1与PPARγ之间的物理相互作用来抑制RANKL诱导的NFATc1自扩增。
FEBS Open Bio. 2018 Sep 10;8(10):1584-1593. doi: 10.1002/2211-5463.12513. eCollection 2018 Oct.
7
Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology.基于工程化干细胞的血管化骨模型用于药物筛选和预测毒理学研究。
Stem Cell Res Ther. 2018 Apr 20;9(1):112. doi: 10.1186/s13287-018-0847-8.
8
New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.使用抗体组合提高癌症治疗效果的新策略。
Front Immunol. 2017 Dec 21;8:1804. doi: 10.3389/fimmu.2017.01804. eCollection 2017.
9
Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity.白藜芦醇通过上调 FoxO1 转录活性预防骨质疏松症。
Int J Mol Med. 2018 Jan;41(1):202-212. doi: 10.3892/ijmm.2017.3208. Epub 2017 Oct 23.
10
Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis.盐诱导激酶(SIK)抑制可减少核因子κB受体活化因子配体(RANKL)诱导的破骨细胞生成。
PLoS One. 2017 Oct 3;12(10):e0185426. doi: 10.1371/journal.pone.0185426. eCollection 2017.